These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9750529)
1. [Usefulness of initial chemoendocrine therapy for advanced prostate cancer]. Kanetake H; Igawa T; Sakai H; Saito Y Nihon Rinsho; 1998 Aug; 56(8):2173-6. PubMed ID: 9750529 [TBL] [Abstract][Full Text] [Related]
2. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
3. [Keyrole of endocrinology in the victory against prostate cancer]. Labrie F Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238 [TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer. Pummer K; Lehnert M; Stettner H; Hubmer G Eur Urol; 1997; 32 Suppl 3():81-5. PubMed ID: 9267791 [TBL] [Abstract][Full Text] [Related]
6. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR; Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313 [TBL] [Abstract][Full Text] [Related]
7. [Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma]. Bruchovsky N; Goldenberg SL; Rennie PS; Gleave M Urologe A; 1995 Sep; 34(5):389-92. PubMed ID: 7483155 [TBL] [Abstract][Full Text] [Related]
8. Hormone chemotherapy for newly diagnosed patients with metastatic prostate cancer. Kubota Y; Nakada T; Suzuki Y; Iizima Y; Adachi Y; Hashimoto T Int Urol Nephrol; 1993; 25(5):469-74. PubMed ID: 8270375 [TBL] [Abstract][Full Text] [Related]
9. Complete androgen blockade for the treatment of prostate cancer. Labrie F; Dupont A; Belanger A Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740 [No Abstract] [Full Text] [Related]
10. [Recent multicenter study protocols in the USA for patients with metastatic prostatic carcinoma]. DeAntoni E; Crawford ED Urologe A; 1995 Sep; 34(5):382-8. PubMed ID: 7483154 [TBL] [Abstract][Full Text] [Related]
15. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer. Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766 [TBL] [Abstract][Full Text] [Related]
17. [Renaissance of estrogen therapy in advanced prostate carcinoma?]. Smith PH; Robinson MR Urologe A; 1995 Sep; 34(5):393-7. PubMed ID: 7483156 [TBL] [Abstract][Full Text] [Related]